Concepedia

Nadia Swanson

NS

3

Publications

54

Citations

3

H-Index

2010

Active since

Affiliations

Johnson & Johnson (United States)(Current)

Nadia Swanson is an author at Johnson & Johnson (United States) specializing in drug discovery, medicinal chemistry, and medicine.

Top concepts

Publications per year

2010–2018

3

Publications

3

GPR40-Mediated Gα12 Activation by Allosteric Full Agonists Highly Efficacious at Potentiating Glucose-Stimulated Insulin Secretion in Human Islets

M. Rives, Brian Rady, Nadia Swanson et al. · Molecular Pharmacology · 2018 · 26 citations · Full text

Characterization of 2-(2,6-dichloro-benzyl)-thiazolo[5,4-d]pyrimidin-7-yl]-(4-trifluoromethyl-phenyl)-amine (JNJ-39729209) as a novel TRPV1 antagonist

Michael P. Maher, Anindya Bhattacharya, Hong Ao et al. · European Journal of Pharmacology · 2011 · 17 citations

, , +5

Discovery and synthesis of 6,7,8,9-tetrahydro-5H-pyrimido-[4,5-d]azepines as novel TRPV1 antagonists

Natalie A. Hawryluk, Jeffrey E. Merit, Alec D. Lebsack et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 11 citations · Full text

, , +3

Rows per page

1–3 of 3